Energy Shares Rise After Attack on Iran
Energy shares gained ground in Asia after Israel's attack on Iran, in line with the rise in oil prices, while movements in other markets were relatively restrained as investors weighed the potential fallout. Japan's Nikkei average was down 1.2% in afternoon trading Friday, and other Asian markets were down slightly. The dollar and other safe-haven currencies rose.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Dow Jones Futures: Israel Attacks Iran Energy Assets; The Next AI Winners After Nvidia, Broadcom?
Israel expanded its targets Saturday to include Iran energy assets. Will these AI stocks follow Nvidia, Broadcom higher?
Yahoo
30 minutes ago
- Yahoo
Israel and Iran strike at each other in new wave of attacks
By Alexander Cornwell and Parisa Hafezi TEL AVIV/DUBAI (Reuters) -Israel and Iran launched fresh attacks on each other late on Saturday, stoking fears of a wider conflict after Israel expanded its surprise campaign against its main rival with a strike on the world's biggest gas field. Tehran called off nuclear talks that Washington had said were the only way to halt Israel's bombing, while Israeli Prime Minister Benjamin Netanyahu said the attacks were nothing compared with what Iran would see in the coming days. Israel's military said on Saturday that more missiles were launched from Iran towards Israel, and it was working to intercept them. It also said it was attacking military targets in Tehran. Iranian state television said Iran had launched missiles and drones at Israel. Several projectiles were visible in the night sky over Jerusalem late on Saturday. Air raid sirens did not sound in the city, but were heard in the northern Israeli city of Haifa. Israel's ambulance service said 14 people were injured, including one critically, at a two-storey house in northern Israel following an Iranian missile strike. Israeli media reported that one person had been killed in the strike. U.S. President Donald Trump had warned Iran of worse to come, but said it was not too late to halt the Israeli campaign if Tehran accepted a sharp downgrading of its nuclear programme. A round of U.S.-Iran nuclear talks due to be held in Oman on Sunday was canceled, with Iranian Foreign Minister Abbas Araqchi saying the discussions could not take place while Iran was being subjected to Israel's "barbarous" attacks. In the first apparent attack to hit Iran's energy infrastructure, the semi-official Tasnim news agency said Iran partially suspended production at the world's biggest gas field after an Israeli strike caused a fire there on Saturday. The South Pars field, offshore in Iran's southern Bushehr province, is the source of most of the gas produced in Iran. Fears about potential disruption to the region's oil exports had already driven up oil prices 9% on Friday even though Israel spared Iran's oil and gas on the first day of its attacks. An Iranian general, Esmail Kosari, said on Saturday that Tehran was reviewing whether to close the Strait of Hormuz controlling access to the Gulf for tankers. IRAN SAYS SCORES KILLED Iran said 78 people were killed on the first day of Israel's campaign, and scores more on the second, including 60 when a missile brought down a 14-storey apartment block in Tehran, where 29 of the dead were children. Iran had launched its own retaliatory missile volley on Friday night, killing at least three people in Israel. With Israel saying its operation could last weeks, and Netanyahu urging Iran's people to rise up against their Islamic clerical rulers, fears have grown of a regional conflagration dragging in outside powers. B'Tselem, a leading Israeli human rights organization, said on Saturday that instead of exhausting all possibilities for a diplomatic resolution, Israel's government had chosen to start a war that puts the entire region in danger. Tehran has warned Israel's allies that their military bases in the region would come under fire too if they helped shoot down Iranian missiles. However, 20 months of war in Gaza and a conflict in Lebanon last year have decimated Tehran's strongest regional proxies, Hamas in Gaza and Hezbollah in Lebanon, reducing its options for retaliation. Israel sees Iran's nuclear programme as a threat to its existence, and said the bombardment was designed to avert the last steps to production of a nuclear weapon. Tehran insists the programme is entirely civilian and that it does not seek an atomic bomb. However the U.N. nuclear watchdog reported it this week as violating obligations under the global non-proliferation treaty.
Yahoo
an hour ago
- Yahoo
Several Insiders Invested In AFT Pharmaceuticals Flagging Positive News
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in AFT Pharmaceuticals Limited's (NZSE:AFT) instance, it's good news for shareholders. Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Over the last year, we can see that the biggest insider purchase was by Independent Non-Executive Director Andrew Lane for NZ$257k worth of shares, at about NZ$2.71 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being NZ$2.66). It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels. AFT Pharmaceuticals insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! Check out our latest analysis for AFT Pharmaceuticals AFT Pharmaceuticals is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying. Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that AFT Pharmaceuticals insiders own 69% of the company, worth about NZ$193m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders. It doesn't really mean much that no insider has traded AFT Pharmaceuticals shares in the last quarter. However, our analysis of transactions over the last year is heartening. Judging from their transactions, and high insider ownership, AFT Pharmaceuticals insiders feel good about the company's future. Of course, the future is what matters most. So if you are interested in AFT Pharmaceuticals, you should check out this free report on analyst forecasts for the company. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
